SCHEMBL4744105

SCHEMBL4744105

C=CC1CC2(CCN1Cc1ccccc1)C(NC1CCCCC1)=NC(=O)N2c1cccc(F)c1

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 7/20 0.45
ADORA3 P0DMS8 3/20 0.38
ADORA2A P29274 3/20 0.38
ADORA1 P30542 2/20 0.38
BACE2 Q9Y5Z0 1/20 0.37
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CACNA1G O43497 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ALDH1A1 P00352 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
CDK9 P50750 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL754906 1.00 BACE1 (0.45) BACE1ADORA3ADORA2AADORA1BACE2
SCHEMBL756907 0.89 BACE1 (0.44) BACE1BACE2
SCHEMBL756849 0.89 BACE1 (0.44) BACE1BACE2
SCHEMBL764637 0.88 BACE1 (0.47) BACE1ADORA3ADORA2AADORA1BACE2
SCHEMBL755086 0.87 BACE1 (0.39) BACE1BACE2
SCHEMBL593161 0.84 BACE1 (0.59) BACE1ADORA3ADORA2AADORA1BACE2
SCHEMBL754907 0.82 BACE1 (0.47) BACE1
SCHEMBL756995 0.81 BACE1 (0.47) BACE1
SCHEMBL757422 0.81 BACE1 (0.44) BACE1BACE2
SCHEMBL755926 0.81 BACE1 (0.44) BACE1BACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910364-A2 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Merck & Co., Inc. (US) 2008-04-16 EP claimed
WO-2007011833-A2 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2007-01-25 WO claimed
EP-1910364-A2 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Merck & Co., Inc. (US) 2008-04-16 EP disclosed
WO-2007011833-A2 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2007-01-25 WO disclosed